Caricamento...
Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
INTRODUCTION: Mucopolysaccharidosis Type II (MPS II; Hunter syndrome) is an X- linked lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase (IDS). IDS deficiency leads to primary accumulation of dermatan sulfate (DS) and heparan sulfate (HS). MPS II is both multi-systemic and pr...
Salvato in:
| Pubblicato in: | Expert Opin Orphan Drugs |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693349/ https://ncbi.nlm.nih.gov/pubmed/29158997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2017.1296761 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|